Journal of Literature Pharmacy Sciences

Dental Tedaviler ve Koruyucu Diş Hekimliğinde Önemli Bir Yere Sahip Remineralizasyon Ajanları ve Nanofarmasötik Yaklaşımlar: Geleneksel Derleme
Remineralization Agents and Nanopharmaceutical Approaches That Have an Important Place in Dental Therapies and Preventive Dentistry: Traditional Review
A. Alper ÖZTÜRKa, Sedef ARSLANb
aAnadolu Üniversitesi Eczacılık Fakültesi, Farmasötik Teknoloji ABD, Eskişehir, Türkiye
bSerbest Diş Hekimi, Eskişehir, Türkiye
J Lit Pharm Sci. 2023;12(1):92-100
doi: 10.5336/pharmsci.2022-94536
Article Language: TR
Full Text
ÖZET
 Nanoteknoloji yaklaşımları ile farklı yapıların kendilerine özgü özelliklerinden yararlanmak üzere geliştirilen nanofarmasötikler teşhis, tedavi ve teranöstik uygulamalarda oldukça yararlı sonuçlar vermektedir. Literatür incelendiğinde, özellikle teşhis ve tedavi etkinliğinin artmasında, düşük doz etken madde kullanarak yan etkilerin azalmasında nanofarmasötiklerin yarınımız için umut verici olduğunu göstermektedir. Nanofarmasötik olarak kullanılan nanopartikül formülasyonlarının geleneksel ilaç taşıyıcı sistemlere göre üstünlükleri klinik ve literatür açısından oldukça açıktır. Diş hekimliğinde kullanılan nanoteknolojik yaklaşımlar ve nanofarmasötiklere örnek olarak; nanokompozitler, nanocam iyonomerler, nanoseramikler, seramik nano hücreler, nanometaller, nanoteknolojik restoratif materyaller, nanoteknolojik protez malzemeleri ve diş implantları, nanoteknolojik ortodontik cihazlar, nanoteknolojik endodonti cihazları, nanorobotlar, nano lokal anestezikler, nano iğneler, ortodontide kullanılan nanorobotlar, teşhis aşamasında kullanılan nanorobotlar, görüntülemede nanopartiküller, kemik dokusu mühendisliğinde nanoteknoloji verilmektedir. Artan dünya nüfusu ile ağız diş sağlığı tedavi ihtiyacıyla koruyucu diş hekimliği uygulamaları da hızla gelişmektedir. Diş dokusunda oluşan demineralizasyon ve remineralizasyon, ağız içinde belirli bir denge içindedir ve bu dengenin demineralizasyon yönünde bozulması, çürük oluşumunu başlatmaktadır. Demineralizasyon ve remineralizasyon döngüsü, çürüğün prognozunu belirlemektedir. Demineralizasyon, minenin kristal yapıdaki yüzeyinden başlarken, remineralizasyon ise bu kavitasyon gözlenmeyen lezyonların doğal olarak onarılması olarak tanımlanabilir. Remineralizasyon ajanları koruyucu diş hekimliğinde diş çürüklerinin önlenmesi açısından oldukça önemli bir yere sahiptir. Bu derleme kapsamında, öncelikle literatürde sıklıkla geçen ve klinikte rutin kullanıma girmiş remineralizasyon ajanlarından bahsedilmiş olup, ardından literatürde yer alan remineralizasyon ajanları ile hazırlanmış nanofarmasötikler hakkında bilgi verilmiştir. Bu derlemenin, eczacılar ve diş hekimlerine bir öngörü sunacağı düşünülmektedir.

Anahtar Kelimeler: Nanoteknoloji; nanofarmasötik; koruyucu diş hekimliği; remineralizayon ajanları
ABSTRACT
 Nanopharmaceuticals developed to take advantage of the unique properties of different structures with nanotechnology approaches give very useful results in diagnosis, treatment and therapeutic applications. A review of the literature shows that nanopharmaceuticals are promising for our future, especially in increasing the effectiveness of diagnosis and treatment, reducing side effects by using low-dose active substances. The advantages of nanoparticle formulations used as nanopharmaceuticals over conventional drug delivery systems are quite clear in terms of clinical and literature. Examples of nanotechnological approaches and nanopharmaceuticals used in dentistry are; nanocomposites, nanoglass ionomers, nanoceramics, ceramic nano cells, nanometals, nanotechnological restorative materials, nanotechnological prosthetic materials and dental implants, nanotechnological orthodontic devices, nanotechnological endodontic devices, nanorobots, nano local anesthetics, nano needles, nanorobots used in orthodontics , nanorobots used in diagnosis, nanoparticles in imaging, nanotechnology in bone tissue engineering are given. With the increasing world population and the need for oral and dental health treatment, preventive dentistry practices are also developing rapidly. Demineralization and remineralization in the dental tissue are in a certain balance in the mouth, and the deterioration of this balance in the direction of demineralization initiates the formation of caries. The demineralization and remineralization cycle determines the prognosis of caries. While demineralization starts from the crystalline surface of the enamel, remineralization can be defined as the natural repair of lesions in which this cavitation is not observed. Remineralization agents have a very important place in preventive dentistry in terms of preventing dental caries. Within the scope of this review, first of all, remineralization agents that are frequently used in the literature and routinely used in the clinic are mentioned, and then information about nanopharmaceuticals prepared with remineralization agents in the literature is given. It is thought that this review will provide a foresight to pharmacists and dentists.

Keywords: Nanotechnology; nanopharmaceutical; preventive dentistry; remineralizing agents
REFERENCES:
  1. Öztürk-Atar K, Eroğlu H, Çalış S. Novel advances in targeted drug delivery. J Drug Target. 2018;26(8):633-42. [Crossref]  [PubMed] 
  2. Ozturk A, Aygül A. Design of cefaclor monohydrate containing nanoparticles with extended antibacterial effect by nano-spray dryer: a nanoenglobing study. J Res Pharm. 2020;24(1):100-11. [Crossref] 
  3. Nagarwal RC, Kant S, Singh PN, Maiti P, Pandit JK. Polymeric nanoparticulate system: a potential approach for ocular drug delivery. J Control Release. 2009;136(1):2-13. [Crossref]  [PubMed] 
  4. Mudshinge SR, Deore AB, Patil S, Bhalgat CM. Nanoparticles: emerging carriers for drug delivery. Saudi Pharm J. 2011;19(3):129-41. [Crossref]  [PubMed]  [PMC] 
  5. Bilensoy E. Nanopartiküller. Gürsoy A, editör. Nanofarmasötikler ve Uygulamaları. 1. Baskı. İstanbul: Kontrollü Salım Sistemleri Derneği Yayınları; 2014. p.23-9.
  6. Okunev I, Tranby EP, Jacob M, Diep VK, Kelly A, Heaton LJ, et al. The impact of underutilization of preventive dental care by adult Medicaid participants. J Public Health Dent. 2022;82(1):88-98. [Crossref]  [PubMed]  [PMC] 
  7. Hannig M, Hannig C. Nanomaterials in preventive dentistry. Nat Nanotechnol. 2010;5(8):565-9. [Crossref]  [PubMed] 
  8. Savaş S, Küçükyilmaz E. Diş hekimliğinde kullanılan remineralizasyon ajanları ve çürük önleyici ajanlar [Remineralization agents and caries preventive agents used in dentistry]. J Dent Fac Atatürk Uni. 2014;24(3):113-25. [Link] 
  9. Ghods K, Akbari P, Dehghani Ashkezari P, Ghayoomi S. Newest developments of nanotechnology in dentistry: a review of literature. Journal of Dental Materials and Techniques. 2022;11(1):1-10. [Crossref] 
  10. Hench LL, West JK. Biological Applications of Bioactive Glasses. Life Chemistry Reports. 1996;13:187-241.
  11. Ergin E, Eden E. Mine lezyonlarının farklı ajanlarla remineralizasyonu [The remineralization of enamel lesions with different agents]. Turkiye Klinikleri Journal of Pediatric Dentistry-Special Topics. 2015;1(3):57-64. [Link] 
  12. Ceyhan T, Günay V, Capoğlu A, Sayrak H, Karaca C. Bir cam-seramik biyomalzemenin üretimi, tanımlanması ve biyolojik etkilerinin canlı-dişi ve canlı-içi ortamda değerlendirilmesi [Production and characterization of a glass-ceramic biomaterial and in vitro and in vivo evaluation of its biological effects]. Acta Orthop Traumatol Turc. 2007;41(4):307-13. [PubMed] 
  13. Rodrigues E, Delbem AC, Pedrini D, Cavassan L. Enamel remineralization by fluoride-releasing materials: proposal of a pH-cycling model. Braz Dent J. 2010;21(5):446-51. [Crossref]  [PubMed] 
  14. Buzalaf MAR, Levy SM. Fluoride Intake of Children: Considerations for Dental Caries and Dental Fluorosis. Buzalaf MAR, ed. Fluoride and the Oral Environment. Monogr Oral Sci. Basel, Karger, 2011. vol 22. p.1-19. [Crossref]  [PubMed] 
  15. Marinho VC, Higgins JP, Sheiham A, Logan S. Fluoride toothpastes for preventing dental caries in children and adolescents. Cochrane Database Syst Rev. 2003;2003(1):CD002278. [Crossref]  [PubMed]  [PMC] 
  16. Wong MC, Glenny AM, Tsang BW, Lo EC, Worthington HV, Marinho VC. Topical fluoride as a cause of dental fluorosis in children. Cochrane Database Syst Rev. 2010;2010(1):CD007693. [Crossref]  [PubMed]  [PMC] 
  17. Dionysopoulos D, Gerasimidou O, Papadopoulos C. Current modifications of dental adhesive systems for composite resin restorations: a review in literature. J Adhes Sci Technol. 2022;36(5):453-68. [Crossref] 
  18. Hiraishi N, Sono R, Islam MS, Otsuki M, Tagami J, Takatsuka T. Effect of hesperidin in vitro on root dentine collagen and demineralization. J Dent. 2011;39(5):391-6. [Crossref]  [PubMed] 
  19. Niu LN, Zhang W, Pashley DH, Breschi L, Mao J, Chen JH, et al. Biomimetic remineralization of dentin. Dent Mater. 2014;30(1):77-96. [Crossref]  [PubMed]  [PMC] 
  20. Lv KL, Zhang JX, Meng XC, Li XY. Remineralization effect of the nano-HA toothpaste on artificial caries. Key Engineering Materials. 2007;267-70. [Crossref] 
  21. Yamagishi K, Onuma K, Suzuki T, Okada F, Tagami J, Otsuki M, et al. Materials chemistry: a synthetic enamel for rapid tooth repair. Nature. 2005;433(7028):819. [Crossref]  [PubMed] 
  22. Huang SB, Gao SS, Yu HY. Effect of nano-hydroxyapatite concentration on remineralization of initial enamel lesion in vitro. Biomed Mater. 2009;4(3):034104. [Crossref]  [PubMed] 
  23. Rao A, Malhotra N. The role of remineralizing agents in dentistry: a review. Compend Contin Educ Dent. 2011;32(6):26-33; quiz 34, 36. [PubMed] 
  24. Takatsuka T, Exterkate RA, ten Cate JM. Effects of Isomalt on enamel de- and remineralization, a combined in vitro pH-cycling model and in situ study. Clin Oral Investig. 2008;12(2):173-7. [Crossref]  [PubMed] 
  25. To-o K, Kamasaka H, Nishimura T, Kuriki T, Saeki S, Nakabou Y. Absorbability of calcium from calcium-bound phosphoryl oligosaccharides in comparison with that from various calcium compounds in the rat ligated jejunum loop. Biosci Biotechnol Biochem. 2003;67(8):1713-8. [Crossref]  [PubMed] 
  26. Cury JA, Simões GS, Del Bel Cury AA, Gonçalves NC, Tabchoury CP. Effect of a calcium carbonate-based dentifrice on in situ enamel remineralization. Caries Res. 2005;39(3):255-7. [Crossref]  [PubMed] 
  27. Walker GD, Cai F, Shen P, Bailey DL, Yuan Y, Cochrane NJ, et al. Consumption of milk with added casein phosphopeptide-amorphous calcium phosphate remineralizes enamel subsurface lesions in situ. Aust Dent J. 2009;54(3):245-9. [Crossref]  [PubMed] 
  28. Ardu S, Castioni NV, Benbachir N, Krejci I. Minimally invasive treatment of white spot enamel lesions. Quintessence Int. 2007;38(8):633-6. [PubMed] 
  29. Mm J, Nk B, A P. Minimal intervention dentistry - a new frontier in clinical dentistry. J Clin Diagn Res. 2014;8(7):ZE04-8. [PubMed]  [PMC] 
  30. Cochrane NJ, Saranathan S, Cai F, Cross KJ, Reynolds EC. Enamel subsurface lesion remineralisation with casein phosphopeptide stabilised solutions of calcium, phosphate and fluoride. Caries Res. 2008;42(2):88-97. [Crossref]  [PubMed] 
  31. Shibasaki K, Sano H, Matsukubo T, Takaesu Y. Effects of low molecular chitosan on pH changes in human dental plaque. Bull Tokyo Dent Coll. 1994;35(1):33-9. [PubMed] 
  32. Petri DF, Donegá J, Benassi AM, Bocangel JA. Preliminary study on chitosan modified glass ionomer restoratives. Dent Mater. 2007;23(8):1004-10. [Crossref]  [PubMed] 
  33. Nimbeni SB, Nimbeni BS, Divakar DD. Role of chitosan in remineralization of enamel and dentin: a systematic review. Int J Clin Pediatr Dent. 2021;14(4):562-8. [Crossref]  [PubMed]  [PMC] 
  34. Fujiwara M, Hayashi Y, Ohara N. Inhibitory effect of water-soluble chitosan on growth of Streptococcus mutans. New Microbiol. 2004;27(1):83-6. [PubMed] 
  35. Reynolds EC. Casein phosphopeptide-amorphous calcium phosphate: the scientific evidence. Adv Dent Res. 2009;21(1):25-9. [Crossref]  [PubMed] 
  36. Hedberg M, Hasslöf P, Sjöström I, Twetman S, Stecksén-Blicks C. Sugar fermentation in probiotic bacteria--an in vitro study. Oral Microbiol Immunol. 2008;23(6):482-5. [Crossref]  [PubMed] 
  37. Mäkinen KK. The rocky road of xylitol to its clinical application. J Dent Res. 2000;79(6):1352-5. [Crossref]  [PubMed] 
  38. Amaechi BT, Porteous N, Ramalingam K, Mensinkai PK, Ccahuana Vasquez RA, Sadeghpour A, et al. Remineralization of artificial enamel lesions by theobromine. Caries Res. 2013;47(5):399-405. [Crossref]  [PubMed] 
  39. Cova I, Leta V, Mariani C, Pantoni L, Pomati S. Exploring cocoa properties: is theobromine a cognitive modulator? Psychopharmacology (Berl). 2019;236(2):561-72. [Crossref]  [PubMed] 
  40. Karlinsey RL, Mackey AC, Walker ER, Frederick KE. Surfactant-modified beta-TCP: structure, properties, and in vitro remineralization of subsurface enamel lesions. J Mater Sci Mater Med. 2010;21(7):2009-20. [Crossref]  [PubMed] 
  41. Ekambaram M, Mohd Said SNB, Yiu CKY. A review of enamel remineralisation potential of calcium- and phosphate-based remineralisation systems. Oral Health Prev Dent. 2017;15(5):415-20. [PubMed] 
  42. Zhao W, Wang J, Zhai W, Wang Z, Chang J. The self-setting properties and in vitro bioactivity of tricalcium silicate. Biomaterials. 2005;26(31):6113-21. [Crossref]  [PubMed] 
  43. Dong Z, Chang J, Deng Y, Joiner A. In vitro remineralization of acid-etched human enamel with Ca3SiO5. Applied Surface Science. 2010;256(8):2388-91. [Crossref] 
  44. Wu CD. Grape products and oral health. J Nutr. 2009;139(9):1818S-23S. [Crossref]  [PubMed]  [PMC] 
  45. Benjamin S, Sharma R, Thomas SS, Nainan MT. Grape seed extract as a potential remineralizing agent: a comparative in vitro study. J Contemp Dent Pract. 2012;13(4):425-30. [Crossref]  [PubMed] 
  46. Öztürk AA, Yenilmez E, Şenel B, Kıyan HT, Güven UM. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and in vivo anti-inflammatory effect by using HET-CAM assay. Drug Dev Ind Pharm. 2020;46(4):682-95. [Crossref]  [PubMed] 
  47. Gupta J. Nanotechnology applications in medicine and dentistry. J Investig Clin Dent. 2011;2(2):81-8. [Crossref]  [PubMed] 
  48. Thaitalay P, Giannasi C, Niada S, Thongsri O, Dangviriyakul R, Srisuwan S, et al. Nano-bioactive glass incorporated polymeric apatite/tricalcium phosphate cement composite supports proliferation and osteogenic differentiation of human adipose-derived stem/stromal cells. Materials Today Communications. 2022;31:103590. [Crossref] 
  49. Nguyen OOT, Tran KD, Ha NT, Doan SM, Dinh TTH, Tran TH. Oral cavity: an open horizon for nanopharmaceuticals. J Pharma Investig. 2021;51(4):413-24. [Crossref] 
  50. Nagireddy VR, Reddy D, Kondamadugu S, Puppala N, Mareddy A, Chris A. Nanosilver fluoride-A paradigm shift for arrest in dental caries in primary teeth of schoolchildren: a randomized controlled clinical trial. Int J Clin Pediatr Dent. 2019;12(6):484-90. [Crossref]  [PubMed]  [PMC] 
  51. Pepla E, Besharat LK, Palaia G, Tenore G, Migliau G. Nano-hydroxyapatite and its applications in preventive, restorative and regenerative dentistry: a review of literature. Ann Stomatol (Roma). 2014;5(3):108-14. [PubMed]  [PMC] 
  52. Swarup JS, Rao A. Enamel surface remineralization: using synthetic nanohydroxyapatite. Contemp Clin Dent. 2012;3(4):433-6. [Crossref]  [PubMed]  [PMC] 
  53. Vano M, Derchi G, Barone A, Covani U. Effectiveness of nano-hydroxyapatite toothpaste in reducing dentin hypersensitivity: a double-blind randomized controlled trial. Quintessence Int. 2014;45(8):703-11. [PubMed] 
  54. Kani T, Kani M, Isozaki A, Shintani H, Ohashi T, Tokumoto T. Effect to apatite-containing dentifrices on dental caries in school children. Journal of Dental Health. 1989;39(1):104-9. [Crossref] 
  55. Niwa M, Sato T, Li W, Aoki H, Aoki H, Daisaku T. Polishing and whitening properties of toothpaste containing hydroxyapatite. J Mater Sci Mater Med. 2001;12(3):277-81. [Crossref]  [PubMed] 
  56. Colombo M, Beltrami R, Rattalino D, Mirando M, Chiesa M, Poggio C. Protective effects of a zinc-hydroxyapatite toothpaste on enamel erosion: SEM study. Ann Stomatol (Roma). 2017;7(3):38-45. [PubMed]  [PMC] 
  57. Carrouel F, Viennot S, Ottolenghi L, Gaillard C, Bourgeois D. Nanoparticles as anti-microbial, anti-inflammatory, and remineralizing agents in oral care cosmetics: a review of the current situation. Nanomaterials (Basel). 2020;10(1):140. [Crossref]  [PubMed]  [PMC] 
  58. Ramis JM, Coelho CC, Córdoba A, Quadros PA, Monjo M. Safety assessment of nano-hydroxyapatite as an oral care ingredient according to the EU cosmetics regulation. Cosmetics. 2018;5(3):53. [Crossref] 
  59. Rao SK, Bhat GS, Aradhya S, Devi A, Bhat M. Study of the efficacy of toothpaste containing casein phosphopeptide in the prevention of dental caries: a randomized controlled trial in 12- to 15-year-old high caries risk children in Bangalore, India. Caries Res. 2009;43(6):430-5. [Crossref]  [PubMed] 
  60. Poggio C, Lombardini M, Colombo M, Bianchi S. Impact of two toothpastes on repairing enamel erosion produced by a soft drink: an AFM in vitro study. J Dent. 2010;38(11):868-74. [Crossref]  [PubMed] 
  61. Elgamily H, Safwat E, Soliman Z, Salama H, El-Sayed H, Anwar M. Antibacterial and remineralization efficacy of casein phosphopeptide, glycomacropeptide nanocomplex, and probiotics in experimental toothpastes: an in vitro comparative study. Eur J Dent. 2019;13(3):391-8. [Crossref]  [PubMed]  [PMC] 
  62. Tao S, He L, Xu HHK, Weir MD, Fan M, Yu Z, et al. Dentin remineralization via adhesive containing amorphous calcium phosphate nanoparticles in a biofilm-challenged environment. J Dent. 2019;89:103193. [Crossref]  [PubMed] 
  63. Wang H, Xiao Z, Yang J, Lu D, Kishen A, Li Y, et al. Oriented and ordered biomimetic remineralization of the surface of demineralized dental enamel using HAP@ACP nanoparticles guided by glycine. Sci Rep. 2017;7:40701. [Crossref]  [PubMed]  [PMC] 
  64. Burwell A, Jennings D, Muscle D, Greenspan DC. NovaMin and dentin hypersensitivity--in vitro evidence of efficacy. J Clin Dent. 2010;21(3):66-71. [PubMed] 
  65. Sheng XY, Gong WY, Hu Q, Chen XF, Dong YM. Mineral formation on dentin induced by nano-bioactive glass. Chinese Chemical Letters. 2016;27(9):1509-14. [Crossref] 
  66. Dai LL, Mei ML, Chu CH, Lo ECM. Mechanisms of bioactive glass on caries management: a review. Materials (Basel). 2019;12(24):4183. [Crossref]  [PubMed]  [PMC] 
  67. Han X, Erkan A, Xu Z, Chen Y, Boccaccini AR, Zheng K. Organic solvent-free synthesis of dendritic mesoporous bioactive glass nanoparticles with remineralization capability. Materials Letters. 2022;320:132366. [Crossref] 
  68. Ahmed O, Sibuyi NRS, Fadaka AO, Madiehe MA, Maboza E, Meyer M, et al. Plant extract-synthesized silver nanoparticles for application in dental therapy. Pharmaceutics. 2022;14(2):380. [Crossref]  [PubMed]  [PMC] 
  69. Scarpelli BB, Punhagui MF, Hoeppner MG, Almeida RSC, Juliani FA, Guiraldo RD, et al. In vitro evaluation of the remineralizing potential and antimicrobial activity of a cariostatic agent with silver nanoparticles. Braz Dent J. 2017;28(6):738-43. [Crossref]  [PubMed] 
  70. Favaro JC, Detomini TR, Maia LP, Poli RC, Guiraldo RD, Lopes MB, et al. Anticaries agent based on silver nanoparticles and fluoride: characterization and biological and remineralizing effects-an in vitro study. Int J Dent. 2022;2022:9483589. [Crossref]  [PubMed]  [PMC] 

.: Up To Date

.: Process List

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com